Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Adamas Pharmaceuticals, Inc.. United States. Announced Date 11/10/2021. Closed Date 24/11/2021. Deal value: $450m. Supernus Pharmaceuticals to acquire Adamas Pharmaceuticals. Industry: Adamas Pharmaceuticals, Inc. is a pharmaceutical company focused on developing treatments for chronic neurological disorders.